164 related articles for article (PubMed ID: 19690126)
1. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.
Lakey RL; Cawston TE
Rheumatology (Oxford); 2009 Oct; 48(10):1208-12. PubMed ID: 19690126
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
Milner JM; Rowan AD; Elliott SF; Cawston TE
Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
[TBL] [Abstract][Full Text] [Related]
4. Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases.
Hui W; Litherland GJ; Elias MS; Kitson GI; Cawston TE; Rowan AD; Young DA
Ann Rheum Dis; 2012 Mar; 71(3):455-62. PubMed ID: 22072016
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation.
Barter MJ; Hui W; Lakey RL; Catterall JB; Cawston TE; Young DA
Ann Rheum Dis; 2010 Dec; 69(12):2189-98. PubMed ID: 20693272
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Hui W; Rowan AD; Richards CD; Cawston TE
Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
[TBL] [Abstract][Full Text] [Related]
9. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
10. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
11. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption.
Young DA; Lakey RL; Pennington CJ; Jones D; Kevorkian L; Edwards DR; Cawston TE; Clark IM
Arthritis Res Ther; 2005; 7(3):R503-12. PubMed ID: 15899037
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.
Cleaver CS; Rowan AD; Cawston TE
Ann Rheum Dis; 2001 Feb; 60(2):150-7. PubMed ID: 11156549
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.
Hui W; Rowan AD; Cawston T
Ann Rheum Dis; 2001 Mar; 60(3):254-61. PubMed ID: 11171688
[TBL] [Abstract][Full Text] [Related]
18. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
Shingleton WD; Ellis AJ; Rowan AD; Cawston TE
J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843
[TBL] [Abstract][Full Text] [Related]
20. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
Tchetina EV; Squires G; Poole AR
J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]